Related references
Note: Only part of the references are listed.Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro
F. D. TÓTH et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma
Katie L. Davis et al.
JOURNAL OF VIROLOGY (2009)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid et al.
NATURE (2009)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantaion
Gero Huetter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10
Joshua S. Klein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
Ann J. Hessell et al.
PLOS PATHOGENS (2009)
Personalized Therapeutics: HIV Treatment in Adolescents (vol 84, pg 734, 2008)
N. Y. Rakhmanina et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
A brief history of HIV vaccine research: stepping back to the drawing board?
Frank Miedema
AIDS (2008)
The C-type lectin surface receptor DICIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways
Alexandra A. Lambert et al.
BLOOD (2008)
Personalized Therapeutics: HIV Treatment in Adolescents
N. Y. Rakhmanina et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
CCR5 as target for HIV-1 gene therapy
Reza Nazari et al.
CURRENT GENE THERAPY (2008)
Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells
Neil C. Robson et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Prospects for HIV-1 therapeutic immunisation and vaccination: the potential contribution of peptide immunogens
Maja A. Sommerfelt et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120
Alfredo Menendez et al.
FASEB JOURNAL (2008)
Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins
Mary Requena et al.
IMMUNOLOGY (2008)
HIV/AIDS Vaccines: A Need for New Concepts?
Marc P. Girard et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2008)
Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells
Matthieu Perreau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication
Maria B. Asparuhova et al.
JOURNAL OF GENE MEDICINE (2008)
Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120
Hongying Chen et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Why Do We Not Yet Have a Human Immunodeficiency Virus Vaccine?
Arnold J. Levine
JOURNAL OF VIROLOGY (2008)
Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency
Monica Vaccari et al.
JOURNAL OF VIROLOGY (2008)
Central role of reverting mutations in HLA associations with human immunodeficiency virus set point
Philippa C. Matthews et al.
JOURNAL OF VIROLOGY (2008)
Failure of the Merck HIV vaccine: an uncertain step forward
Merlin L. Robb
LANCET (2008)
HIV immunopathogenesis and strategies for intervention
Martin Cadogan et al.
LANCET INFECTIOUS DISEASES (2008)
CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIVmac251 infection
M. Vaccari et al.
MUCOSAL IMMUNOLOGY (2008)
HIV immunology needs a new direction
Ruslan Medzhitov et al.
NATURE (2008)
Challenges in the development of an HIV-1 vaccine
Dan H. Barouch
NATURE (2008)
Why vaccines are not the answer - The failure of V520 and the importance of cell-mediated immunity in the fight against HIV
Aaron White
MEDICAL HYPOTHESES (2008)
An HIV vaccine - Challenges and prospects
Margaret I. Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions
Joseph G. Joyce et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Designing an effective AIDS vaccine: Strategies and current status
Z. Coutsions et al.
REVUE DE MEDECINE INTERNE (2008)
Residual Viraemia in HIV-1-Infected Patients with Plasma Viral Load ≤20 copies/ml is Associated with Increased Blood Levels of Soluble Immune Activation Markers
S. R. Ostrowski et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
AIDS/HIV - A STEP into darkness or light?
John P. Moore et al.
SCIENCE (2008)
Perspective - HIV vaccine research: The way forward
Anthony S. Fauci et al.
SCIENCE (2008)
Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization
Igor M. Belyakov et al.
VIROLOGY (2008)
Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells
Nicolas Chomont et al.
VIROLOGY (2008)
In vivo efficacy of human immunodeficiency virus neutralizing antibodies:: Estimates for protective titers
Alexandra Trkola et al.
JOURNAL OF VIROLOGY (2008)
Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection
Stephanie Planque et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Severe depletion of mucosal CD4+ T cells in AIDS-Free simian immunodeficiency virus-infected sooty Mangabeys
Shari N. Gordon et al.
JOURNAL OF IMMUNOLOGY (2007)
Reciprocal generation of Th1/Th17 and Treg cells by B1 and B2B cells
Xuemei Zhong et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Neutralization of animal virus infectivity by antibody
S. A. Reading et al.
ARCHIVES OF VIROLOGY (2007)
HIV-1 immunopathogenesis: How good interferon turns bad
Jean-Philippe Herbeuval et al.
CLINICAL IMMUNOLOGY (2007)
Virus recognition by specific natural antibodies and complement results in MHC I cross-presentation
Antoine Durrbach et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity
Jerome P. Jayasekera et al.
JOURNAL OF VIROLOGY (2007)
Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection
C. A. R. Baker et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes
Thijs van Montfort et al.
JOURNAL OF IMMUNOLOGY (2007)
HIV vaccine efficacy trials: Towards the future of HIV prevention
Denny Kim et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2007)
Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner
Hicham Bouhlal et al.
JOURNAL OF IMMUNOLOGY (2007)
Defining carbohydrate antigens as HIV vaccine candidates
Anastas Pashov et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Understanding the failure of CD8(+) T-cell vaccination against simian/human immunodeficiency virus
Rob J. De Boer
JOURNAL OF VIROLOGY (2007)
Acute loss of intestinal CD4(+) T cells is not predictive of simian immunodeficiency virus virulence
Ivona V. Pandrea et al.
JOURNAL OF IMMUNOLOGY (2007)
Specificity of DC-SIGN for mannose- and fucose-containing glycans
Ellis van Liempt et al.
FEBS LETTERS (2006)
Multiple antigenic mimotopes of HIV carbohydrate antigens - Relating structure and antigenicity
Anastas D. Pashov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes
Jan Balzarini et al.
JOURNAL OF VIROLOGY (2006)
Differential susceptibility of naive, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission
Fedde Groot et al.
RETROVIROLOGY (2006)
DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes
Giovanna Rappocciolo et al.
PLOS PATHOGENS (2006)
A review of vaccine research and development: Meningococcal disease
Marc P. Girard et al.
VACCINE (2006)
Proteolytic activity of IgG antibodies from blood of acquired immunodeficiency syndrome patients
ES Odintsova et al.
BIOCHEMISTRY-MOSCOW (2006)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Induction of a protein-targeted catalytic response in autoimmune prone mice: Antibody-mediated cleavage of HIV-1 glycoprotein GP120
NA Ponomarenko et al.
BIOCHEMISTRY (2006)
Protective 'immunity' by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called 'immunological memory'
Rolf M. Zinkernagel et al.
IMMUNOLOGICAL REVIEWS (2006)
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
SDW Frost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12
A Pashov et al.
GLYCOBIOLOGY (2005)
Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens
A Pashov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Reintroduction of the 2G12 epitope in an HIV-1 clade C gp120
HY Chen et al.
AIDS (2005)
Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis
J Balzarini et al.
MOLECULAR PHARMACOLOGY (2005)
Targeting carbohydrate antigens in HIV vaccine development
A Pashov et al.
VACCINE (2005)
Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques
UM Abdel-Motal et al.
VIROLOGY (2005)
Inhibition of HIV-1 infection by monoclonal antibodies to carbohydrates of Schistosoma mansoni
M Antonio et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2005)
Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes
C Marañón et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant
Y Mitsuda et al.
BIOTECHNOLOGY AND BIOENGINEERING (2004)
HIV-Specific CD8+ T cells:: Serial killers condemned to die?
C Petrovas et al.
CURRENT HIV RESEARCH (2004)
Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells
K Attanavanich et al.
JOURNAL OF IMMUNOLOGY (2004)
Toward fully synthetic carbohydrate-based HIV antigen design: On the critical role of bivalency
VY Dudkin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis x trisaccharide and Schistosoma mansoni egg antigens
E Van Liempt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins:: HIV, SIV, and HCV envelopes and influenza hemagglutinin
M Zhang et al.
GLYCOBIOLOGY (2004)
Fucosylated lactosamines participate in adhesion of HIV-1 envelope glycoprotein to dendritic cells
B Monzavi-Karbassi et al.
ARCHIVES OF VIROLOGY (2004)
Potency of HIV-1 envelope glycoprotein gp120 antibodies to inhibit the interaction of DC-SIGN with HIV-1 gp120
AN Lekkerkerker et al.
VIROLOGY (2004)
Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope
L Dacheux et al.
JOURNAL OF VIROLOGY (2004)
Mucosal HIV vaccines: Where are we now?
L Stevceva et al.
CURRENT HIV RESEARCH (2004)
A critical role for induced IgM in the protection against West Nile Virus infection
MS Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: Associations with viral replication and progression
E Keoshkerian et al.
JOURNAL OF MEDICAL VIROLOGY (2003)
DC-sign: Escape mechanism for pathogens
Y van Kooyk et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo
JC Grivel et al.
JOURNAL OF VIROLOGY (2003)
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
DA Calarese et al.
SCIENCE (2003)
Measles virus induces apoptosis in uninfected bystander T cells and leads to granzyme B and caspase activation in peripheral blood mononuclear cell cultures
T Vuorinen et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design
R Pantophlet et al.
JOURNAL OF VIROLOGY (2003)
Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12
S Wolbank et al.
JOURNAL OF VIROLOGY (2003)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia
G Silvestri et al.
IMMUNITY (2003)
Chemoenzymatic synthesis of high-mannose type HIV-1 gp120 glycopeptides
S Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells
A Cambi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Therapeutic vaccination for future management of HIV/AIDS
J Lisziewicz et al.
VACCINE (2003)
Priming characteristics of peptide mimotopes of carbohydrate antigens
B Monzavi-Karbassi et al.
VACCINE (2003)
HIV vaccine development: Lessons from the past and promise for the future
P Spearman
CURRENT HIV RESEARCH (2003)
Neutralizing antibody induced in mice by novel glycoconjugates of human immunodeficiency virus type 1 gp120 and env2-3
LC Paoletti et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: Implications for structural analyses of gp120-DC-SIGN binding
PWP Hong et al.
JOURNAL OF VIROLOGY (2002)
The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens
A Zandvoort et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120
RW Sanders et al.
JOURNAL OF VIROLOGY (2002)
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120
CN Scanlan et al.
JOURNAL OF VIROLOGY (2002)
Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: Influence of the menstrual cycle
PA Kozlowski et al.
JOURNAL OF IMMUNOLOGY (2002)
Therapeutic vaccination against chronic viral infections
P Vandepapelière
LANCET INFECTIOUS DISEASES (2002)
Immunity, immunopathology and vaccines against HIV?
RM Zinkernagel
VACCINE (2002)
Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein:: Effects on protein function and the neutralizing antibody response
MI Quiñones-Kochs et al.
JOURNAL OF VIROLOGY (2002)
Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection
DH O'Connor et al.
NATURE MEDICINE (2002)
The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells
A Engering et al.
JOURNAL OF IMMUNOLOGY (2002)
Vaccine development against HIV-1 - Current perspectives and future directions
RL Edgeworth et al.
IMMUNOLOGIC RESEARCH (2002)
Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR
H Feinberg et al.
SCIENCE (2001)
HIV mucosal vaccine: Nasal immunization with rBCG-V3J1 induces a long term V3J1 peptide-specific neutralizing immunity in Th1- and Th2-deficient conditions
T Hiroi et al.
JOURNAL OF IMMUNOLOGY (2001)
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?
SL Rowland-Jones et al.
IMMUNOLOGY LETTERS (2001)
How can immunology contribute to the control of tuberculosis?
SHE Kaufmann
NATURE REVIEWS IMMUNOLOGY (2001)
Immunostimulating complexes (ISCOMs) for nasal vaccination
KF Hu et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
PWHI Parren et al.
JOURNAL OF VIROLOGY (2001)
Directing the immune response to carbohydrate antigens
G Cunto-Amesty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region
B Losman et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Genetic drift and within-host metapopulation dynamics of HIV-1 infection
SDW Frost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Marginal zone and B1B cells unite in the early response against T-independent blood-borne particulate antigens
F Martin et al.
IMMUNITY (2001)
Skewed maturation of memory HIV-specific CD8 T lymphocytes
P Champagne et al.
NATURE (2001)
Role of natural and immune IgM antibodies in immune responses
M Boes
MOLECULAR IMMUNOLOGY (2000)
Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL
IM Belyakov et al.
JOURNAL OF IMMUNOLOGY (2000)
Natural antibodies and complement link innate and acquired immunity
AF Ochsenbein et al.
IMMUNOLOGY TODAY (2000)
Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite leishmania major
GF Späth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection
N Baumgarth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors
JC Gea-Banacloche et al.
JOURNAL OF IMMUNOLOGY (2000)
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
TBH Geijtenbeek et al.
CELL (2000)
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
JR Mascola et al.
NATURE MEDICINE (2000)
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
TW Baba et al.
NATURE MEDICINE (2000)
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine
DF Nixon et al.
VIROLOGY (2000)
The IgM antibody level against ganglioside GM2 correlates to the disease status of HIV-1-infected patients
XS Wu et al.
MICROBIOLOGY AND IMMUNOLOGY (2000)
How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1
E Hifumi et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2000)
Share Paper
